Review: taking Metoprolol tartrate and Furosemide together


Summary

Drug interactions are reported among people who take Metoprolol tartrate and Furosemide together. This review analyzes the effectiveness and drug interactions between Metoprolol tartrate and Furosemide. It is created by eHealthMe based on reports of 13,887 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Metoprolol tartrate and Furosemide >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Metoprolol Tartrate

Metoprolol tartrate has active ingredients of metoprolol tartrate. It is often used in high blood pressure. (latest outcomes from Metoprolol tartrate 40,569 users)

Furosemide

Furosemide has active ingredients of furosemide. It is often used in high blood pressure. (latest outcomes from Furosemide 90,341 users)

On Aug, 23, 2016

13,887 people who take Metoprolol Tartrate, Furosemide are studied.


Number of reports submitted per year:

Metoprolol tartrate and Furosemide drug interactions.

Drug effectiveness over time:

Metoprolol Tartrate:
  • < 1 month: 20.0% - (2 of 10 people)
  • 1 - 6 months: 42.0% - (8 of 19 people)
  • 6 - 12 months: 27.0% - (3 of 11 people)
  • 1 - 2 years: 17.0% - (5 of 29 people)
  • 2 - 5 years: 29.0% - (9 of 31 people)
  • 5 - 10 years: 76.0% - (19 of 25 people)
  • 10+ years: 71.0% - (10 of 14 people)
  • not specified: 0.0% - (0 of 1 people)
Furosemide:
  • < 1 month: 18.0% - (2 of 11 people)
  • 1 - 6 months: 14.0% - (4 of 28 people)
  • 6 - 12 months: 25.0% - (5 of 20 people)
  • 1 - 2 years: 43.0% - (7 of 16 people)
  • 2 - 5 years: 35.0% - (14 of 39 people)
  • 5 - 10 years: 47.0% - (9 of 19 people)
  • 10+ years: 75.0% - (6 of 8 people)
  • not specified: 75.0% - (3 of 4 people)

Drug effectiveness by gender:

Metoprolol Tartrate:
  • female: 41.0% - (32 of 78 people)
  • male: 38.0% - (24 of 62 people)
Furosemide:
  • female: 33.0% - (26 of 78 people)
  • male: 35.0% - (24 of 67 people)

Drug effectiveness by age:

Metoprolol Tartrate:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 1 people)
  • 30-39: 40.0% - (2 of 5 people)
  • 40-49: 54.0% - (6 of 11 people)
  • 50-59: 51.0% - (15 of 29 people)
  • 60+: 35.0% - (33 of 94 people)
Furosemide:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 1 people)
  • 30-39: 75.0% - (3 of 4 people)
  • 40-49: 36.0% - (4 of 11 people)
  • 50-59: 26.0% - (8 of 30 people)
  • 60+: 35.0% - (35 of 99 people)

Most common drug interactions over time *:

< 1 month:
  • renal failure
  • pain
  • anxiety
  • injury
  • fear
  • dehydration
  • emotional distress
  • multi-organ failure
  • renal injury
  • anhedonia
1 - 6 months:
  • dyspnoea
  • cardiac failure congestive
  • renal failure
  • myocardial infarction
  • coronary artery disease
  • hypertension
  • oedema peripheral
  • nervousness
  • chest pain
  • lightheadedness - fainting
6 - 12 months:
  • death
  • hives
  • blood glucose increased
  • cardiac arrest
  • gastrointestinal haemorrhage
  • malaise
  • renal failure
  • anaemia
  • anxiety disorder due to a general medical condition
  • cardiac failure
1 - 2 years:
  • renal impairment
  • nervousness
  • cardiac failure
  • malaise
  • dehydration
  • cerebrovascular accident
  • lightheadedness - fainting
  • pain
  • shortness of breath
  • swelling of the ankles - feet - legs
2 - 5 years:
  • myocardial infarction
  • insomnia
  • oedema peripheral
  • fatigue
  • nausea
  • cardiac failure
  • pain
  • cardiac failure congestive
  • dyspnoea
  • renal failure
5 - 10 years:
  • intussusception
  • confusion
  • renal failure
  • fall
  • aphasia
  • chest pain
  • chronic fatigue syndrome
  • cognitive disorder
  • emotional distress
  • gastrointestinal haemorrhage
10+ years:
  • confusion
  • fatigue
  • gastrointestinal haemorrhage
  • muscle pain
  • acute respiratory failure
  • anaemia
  • anxiety
  • bradycardia
  • emotional distress
  • pain
not specified:
  • pain
  • dyspnoea
  • cardiac failure congestive
  • anxiety
  • nausea
  • fatigue
  • asthenia
  • oedema peripheral
  • renal failure
  • anaemia

Most common drug interactions by gender *:

female:
  • pain
  • dyspnoea
  • cardiac failure congestive
  • nausea
  • anxiety
  • anaemia
  • fatigue
  • oedema peripheral
  • asthenia
  • fall
male:
  • pain
  • renal failure
  • dyspnoea
  • anxiety
  • cardiac failure congestive
  • injury
  • oedema peripheral
  • asthenia
  • hypotension
  • atrial fibrillation

Most common drug interactions by age *:

0-1:
  • activated partial thromboplastin time prolonged
  • blood creatinine increased
  • blood fibrinogen decreased
  • blood urea increased
  • bronchospasm
  • chronic obstructive pulmonary disease
  • cleft lip and palate
  • congenital diaphragmatic hernia
  • dizziness
  • drug exposure during pregnancy
2-9:
  • accidental exposure
  • cardiac arrest
  • respiratory arrest
  • abasia
  • arthralgia
  • bursitis
  • femur fracture
  • hypothyroidism
  • overdose
  • pain in extremity
10-19:
  • pyrexia
  • death
  • nausea
  • benign intracranial hypertension
  • cardiac failure congestive
  • fall
  • macular degeneration
  • migraine
  • moyamoya disease
  • optic atrophy
20-29:
  • anxiety
  • pain
  • renal failure
  • dyspnoea
  • emotional distress
  • injury
  • nausea
  • back pain
  • asthenia
  • stress
30-39:
  • oedema peripheral
  • pain
  • dyspnoea
  • anxiety
  • hypotension
  • pain in extremity
  • myocardial infarction
  • renal failure
  • hypertension
  • deep vein thrombosis
40-49:
  • pain
  • anxiety
  • nausea
  • renal failure
  • cardiac failure congestive
  • injury
  • emotional distress
  • vomiting
  • fatigue
  • oedema peripheral
50-59:
  • pain
  • anxiety
  • dyspnoea
  • cardiac failure congestive
  • renal failure
  • injury
  • oedema peripheral
  • nausea
  • anaemia
  • emotional distress
60+:
  • pain
  • dyspnoea
  • cardiac failure congestive
  • atrial fibrillation
  • renal failure
  • anxiety
  • nausea
  • asthenia
  • fatigue
  • anaemia

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Metoprolol tartrate and Furosemide?

Can you answer these questions?

More questions for: Metoprolol tartrate, Furosemide

You may be interested in these reviews

More reviews for: Metoprolol tartrate, Furosemide

On eHealthMe, Metoprolol tartrate (metoprolol tartrate) is often used to treat high blood pressure. Furosemide (furosemide) is often used to treat high blood pressure. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.